Head-to-head · Value Score
Vitara RX vs Rejuve Meds
Two GLP-1 deals, scored on the same six factors. Vitara RX lands a Value Score of 91, Rejuve Meds a 75. Here's who gives you the honest lower price — and where each one bites back.
Vitara RX
#4 · Grade A · Best Value
Est. first month
$99/mo
Save ~93% vs brand-nameRejuve Meds
#135 · Grade C+ · Fair Price
Est. first month
From $165/mo (starting dose, compounded)
Save ~88% vs brand-nameThe verdict
Vitara RX takes it on Value Score, 91 to 75 — an est. $99/mo first month, with no teaser step-up baked in. Rejuve Meds isn't out of it: Shoppers wanting transparent, low-cost compounded GLP-1 with no membership fees and HSA/FSA eligibility.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Vitara RX | Rejuve Meds |
|---|---|---|
| Value Score | 91 (A) | 75 (C+) |
| Est. first month | $99/mo | From $165/mo (starting dose, compounded) |
| Save vs brand-name | ~93% | ~88% |
| Semaglutide | $99/mo | From $165/mo (starting dose, compounded) |
| Tirzepatide | $149/mo | From $265/mo (starting dose, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | 49 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Vitara RX
VitaraRx is a direct-to-consumer telehealth marketplace offering compounded semaglutide and tirzepatide at flat per-drug pricing across all doses — no membership or hidden fees.
Why it's a deal
- Among the lowest flat pricing in the market — $99/mo semaglutide and $149/mo tirzepatide, all doses same price
- Names its 503A pharmacy partner (Manifest Pharmacy, Greer SC) — strong supply-chain transparency
- LegitScript Certified
- Publishes the FDA compounded-medication disclaimer
- Covers 49 states with an explicit state list, not vague "most states" language
The fine print
- No corporate legal entity disclosed — only the trade name "VitaraRx"
- No named medical director — all clinical decisions made by independent providers (marketplace model)
- All sales final — no medication returns
- Per-vial mg quantity isn't clearly disclosed, making price comparisons harder
- Doesn't ship to Alaska
Rejuve Meds
Rejuve Meds (Rejuve, Inc.) is a GLP-1 weight-loss telehealth service offering doctor-guided compounded semaglutide at $165/mo and dual-action compounded tirzepatide (GLP-1/GIP) at $265/mo, with no…
Why it's a deal
- Transparent published pricing: compounded semaglutide $165/mo, tirzepatide $265/mo
- No membership fees — everything is included; free shipping
- HSA/FSA eligible; intro pricing from $85 for the first month
- Doctor-guided programs with personalized care
- Names a "Rejuve Meds Pharmacy Network" for fulfillment
The fine print
- Individual compounding pharmacies not named (only a "pharmacy network")
- Prescribing medical group not named
- States of operation not published
- Not LegitScript-certified (no certification displayed)
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Vitara RX is ranked on the Vitara RX alternatives board, and the same list for the other side is on alternatives to Rejuve Meds.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.